Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07098676Enrolling By Invitation

Haemodialysis Alters Hypercoagulability of Blood in Dialysis Patients

Role: lead

NCT07058441Active Not Recruiting

Clinical and Mechanistic Research on Autogenous Arteriovenous Fistula in Hemodialysis Patients

Role: lead

NCT05522504Active Not Recruiting

Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout

Role: lead

NCT05531825Unknown

Clinical Evaluation Study of a Device for Detecting Arteriovenous Fistula Vascular Function

Role: lead

NCT04600219Unknown

The Effect of Tyrosine Kinase Receptor Axl on Dialysis Prognosis in Chronic Hemodialysis Patients

Role: lead

NCT04352153Not ApplicableUnknown

Role of Uralyt-U in Patients With Hyperuricemia

Role: lead

NCT01709604Completed

Role of CVVH in Patients With Acute Paraquat Poisoning

Role: lead

All 7 trials loaded